“A Study to Investigate the Safety and Efficacy of a Probiotic on Gastrointestinal Health in Healthy Adults”
Eligible participants will be randomized and receive either the probioic or placebo supplement to consume daily for 28-days. Three check-in visits will occur every 7 days of study participation. Participants will be expected to complete a daily study diary documenting their investigational product use/adverse events and a daily bowel habits diary documenting each bowel movement. Blood samples, stool samples, and questionnaires will be completed for study outcome analysis.
Dietary Supplement - Lactobacillus plantarum 276
5 Billion CFU/dose, serving size = 1 capsule/day
Placebo product, serving size = 1 capsule/day
A Randomized, Double-blind, Placebo-controlled, Parallel, Research Study to Investigate the Safety and Efficacy of a Probiotic Lactobacillus Plantarum 276 (Lp276) on Gastrointestinal Health in Healthy Adults